tm logo
THERORNA
Live/Registered
REGISTERED

on 12 Sep 2023

Last Applicant/ Owned by

No.1 Yongtaizhuang North Road

Haidian Dist., Beijing

CN

100082

Serial Number

90796130 filed on 25th Jun 2021

Registration Number

7159975 registered on 12th Sep 2023

in the Principal Register

Correspondent Address

Paulo A. de Almeida

Paulo A. de Almeida

16830 VENTURA BLVD., SUITE 360

ENCINO, CA 91436

Filing Basis

No Filing Basis

Disclaimer

NO DATA

THERORNA

Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for prote Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human biomedicine, namely, pharmaceutical preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; vaccines; drugs for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; opotherapy preparations; serotherapeutic medicines, namely, medical immune serums used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; biological preparations for medical purposes, namely, biological preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; medicines for human purposes, namely, medicines used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; chemical preparations for medical purposes, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and new coronavirus vaccine; adjuvants for medical purposes; Blood for medical purposes; nutraceutical preparations for therapeutic or medical purposes; immunostimulants; Medical cell function activating drugs, namely, medicinal preparations used for protein replacement therapy, cardiovascular therapy, liver disease therapy, cancer therapy, respiratory disease therapy, infectious disease therapy, neurological disease therapy, and for use as a new coronavirus vaccine; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; tumor suppressing agents; Anti-sarcoma preparations; cytostatics for medical purposes; Pharmaceutical products for the prevention and treatment of cancer; all the foregoing using circular ribonucleic acid (RNA)

Mark Details


Serial Number

No 90796130

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Sep 2023REGISTERED-PRINCIPAL REGISTER
12th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
27th Jun 2023PUBLISHED FOR OPPOSITION
27th Jun 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th Jun 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19th May 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
12th May 2023EXAMINERS AMENDMENT -WRITTEN
12th May 2023EXAMINERS AMENDMENT E-MAILED
12th May 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12th May 2023EXAMINER'S AMENDMENT ENTERED